SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-057708
Filing Date
2017-11-09
Accepted
2017-11-09 16:02:36
Documents
65
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv478434_10q.htm 10-Q 416303
2 EXHIBIT 31.1 tv478434_ex31-1.htm EX-31.1 9608
3 EXHIBIT 31.2 tv478434_ex31-2.htm EX-31.2 9805
4 EXHIBIT 32.1 tv478434_ex32-1.htm EX-32.1 5025
5 EXHIBIT 32.2 tv478434_ex32-2.htm EX-32.2 4954
  Complete submission text file 0001144204-17-057708.txt   4162304

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20170930.xml EX-101.INS 850730
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20170930.xsd EX-101.SCH 39788
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20170930_cal.xml EX-101.CAL 37996
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20170930_def.xml EX-101.DEF 305064
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20170930_lab.xml EX-101.LAB 305468
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20170930_pre.xml EX-101.PRE 338302
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 171190683
SIC: 2834 Pharmaceutical Preparations